Cytosorbents (CTSO) News Today → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free CTSO Stock Alerts $0.89 +0.00 (+0.25%) (As of 11:55 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5, 2024 | globenewswire.comCytoSorbents to Host its 2024 Virtual Annual Stockholders MeetingJune 3, 2024 | americanbankingnews.comCytosorbents (NASDAQ:CTSO) Research Coverage Started at StockNews.comMay 15, 2024 | finance.yahoo.comCTSO: CytoSorbents reports 1st quarter 2024 financial results and highlighted STAR-T trial data presentation at the AATS conference.May 15, 2024 | finance.yahoo.comCTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00May 12, 2024 | finance.yahoo.comCytosorbents First Quarter 2024 Earnings: In Line With ExpectationsMay 10, 2024 | finance.yahoo.comCytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call TranscriptMay 9, 2024 | globenewswire.comCytoSorbents Reports First Quarter 2024 ResultsMay 9, 2024 | markets.businessinsider.comHere's what Wall Street expects from Cytosorbents's earningsMay 7, 2024 | markets.businessinsider.comHold Rating on Cytosorbents Amid Regulatory Uncertainties and Mixed Clinical ResultsMay 2, 2024 | finance.yahoo.comCytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in EuropeApril 26, 2024 | globenewswire.comCytoSorbents to Report First Quarter 2024 Operating and Financial ResultsApril 17, 2024 | finance.yahoo.comSTAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual MeetingApril 4, 2024 | finance.yahoo.comCTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2024.April 4, 2024 | finance.yahoo.comCTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2023.March 16, 2024 | finance.yahoo.comCytosorbents Full Year 2023 Earnings: Misses ExpectationsMarch 16, 2024 | finance.yahoo.comCTSO Apr 2024 2.500 callMarch 15, 2024 | finance.yahoo.comQ4 2023 Cytosorbents Corp Earnings CallMarch 15, 2024 | finance.yahoo.comCytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | benzinga.comRecap: CytoSorbents Q4 EarningsMarch 14, 2024 | globenewswire.comCytoSorbents Reports Fourth Quarter and Full Year 2023 ResultsMarch 13, 2024 | markets.businessinsider.comCytosorbents earnings preview: what to expectMarch 6, 2024 | globenewswire.comCytoSorbents to Report Fiscal 2023 Operating and Financial ResultsMarch 4, 2024 | finance.yahoo.comCTSO Mar 2024 2.500 callFebruary 27, 2024 | money.usnews.comCytosorbents CorpFebruary 23, 2024 | finance.yahoo.comCytosorbents (NASDAQ:CTSO) investors are sitting on a loss of 90% if they invested three years agoFebruary 22, 2024 | benzinga.comCytoSorbents Stock (NASDAQ:CTSO) Insider TradesFebruary 22, 2024 | benzinga.comCytoSorbents Stock (NASDAQ:CTSO) Dividends: History, Yield and DatesFebruary 8, 2024 | finance.yahoo.comCytoSorbents to Present at the TD Cowen 44th Annual Health Care ConferenceJanuary 17, 2024 | finance.yahoo.comCTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.January 17, 2024 | finance.yahoo.comGroundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant PatientsJanuary 6, 2024 | stockhouse.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSODecember 30, 2023 | msn.comHC Wainwright & Co. Downgrades Cytosorbents (CTSO)December 30, 2023 | markets.businessinsider.comCytoSorbents Holds Steady with Neutral Rating Amid Clinical and Financial ReassessmentsDecember 29, 2023 | realmoney.thestreet.comCytoSorbents just downgraded at H.C. Wainwright, here's whyDecember 29, 2023 | markets.businessinsider.comWhat To Know About HC Wainwright & Co.'s Downgrade of CytoSorbentsDecember 28, 2023 | markets.businessinsider.comCytoSorbents: DrugSorb-ATR Study Fails To Meet Primary Effectiveness EndpointDecember 28, 2023 | finance.yahoo.comCytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board RecommendationDecember 18, 2023 | finance.yahoo.comInsider Spends US$100k Buying More Shares In CytosorbentsDecember 16, 2023 | finance.yahoo.comInsider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)December 13, 2023 | finance.yahoo.comCytoSorbents Announces Closing of $10.3 Million Registered Direct OfferingNovember 14, 2023 | finance.yahoo.comCTSO: CytoSorbents reports 3rd quarter 2023 financial and operating results which showed strong product revenue growth and an improved cost structure.November 12, 2023 | seekingalpha.comCytosorbents Corporation (CTSO) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | washingtonpost.comCytoSorbents: Q3 Earnings SnapshotNovember 9, 2023 | finance.yahoo.comCytoSorbents Reports Third Quarter 2023 Financial and Operational ResultsNovember 8, 2023 | markets.businessinsider.comHere's what Wall Street expects from Cytosorbents's earnings reportOctober 27, 2023 | finance.yahoo.comCytoSorbents to Report Third Quarter 2023 Operating and Financial ResultsOctober 5, 2023 | finance.yahoo.comCytoSorbents to Present at the 8th Annual Dawson James ConferenceSeptember 27, 2023 | finance.yahoo.comCytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR RegistrySeptember 19, 2023 | markets.businessinsider.comCytoSorbents Announces Reappointment Of Kathleen Bloch As Full-time CFOSeptember 19, 2023 | finance.yahoo.comCytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution CTSO Media Mentions By Week CTSO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼0.000.76▲Average Medical News Sentiment CTSO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼11▲CTSO Articles Average Week Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TLSI News Today NPCE News Today PROF News Today ARAY News Today DRTS News Today CLPT News Today CVRX News Today QIPT News Today TELA News Today BWAY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored